Warning: Contains SPOILERS for The Handmaid's Tale season 6, episode 3! New Bethlehem is the product of Commander Lawrence's big The Handmaid's Tale season 6 plan, and here's what it is and how it ...

Gilead Sciences, Inc. (NASDAQ:GILD) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business day ...

Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Gilead is hoping to break ground early next year on its Chess Hatch campus as part of its plans to expand its presence in ...

Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology ...

Ever wondered if Gilead Sciences might be trading for less than it's worth? Let’s dig into its recent moves to see if there's ...

Gilead Sciences (NASDAQ: GILD) recently broke its 52-week high and is up over 40% over the past six months. As a leading biopharmaceutical company dedicated to pioneering innovative therapies, Gilead ...

Gilead's current market cap attributes little value to its growth potential. I present Bear/Base/Bull valuation scenarios and the implied value of growth. Gilead's proven record for sophisticated, ...

Investors with a lot of money to spend have taken a bullish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the positions showed up on publicly ...

According to Benzinga Pro, Gilead Sciences Inc's peer group average for short interest as a percentage of float is 6.89%, which means the company has less short interest than most of its peers. Did ...